Alkermes
preclinical data demonstrated differential clearance of targeted subunits to minimize systemic exposure tumor and serum from pet imaging of tumor targeted subunits subunit concentration subunit concentration tumor blood hours tumor blood hours tumor clearance of targeted subunits was than serum clearance facilitating tumor specific assembly alkermes internal data on file a a | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
106 of 144
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io